68 related articles for article (PubMed ID: 32158264)
1. ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway.
Zhan W; Li Y; Liu X; Zheng C; Fu Y
Cancer Manag Res; 2020; 12():599-610. PubMed ID: 32158264
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (
Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y
Front Oncol; 2019; 9():342. PubMed ID: 31134149
[TBL] [Abstract][Full Text] [Related]
3. FAM110B Inhibits Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Inactivating Wnt/β-Catenin Signaling.
Xie M; Cai L; Li J; Zhao J; Guo Y; Hou Z; Zhang X; Tian H; Li A; Miao Y
Onco Targets Ther; 2020; 13():4373-4384. PubMed ID: 32547070
[TBL] [Abstract][Full Text] [Related]
4. Smoking behavior associated upregulation of SERPINB12 promotes proliferation and metastasis via activating WNT signaling in NSCLC.
Zheng HZ; Miao X; Chang J; Zhou H; Zhang JJ; Mo HM; Jia Q
J Cardiothorac Surg; 2024 Mar; 19(1):141. PubMed ID: 38504347
[TBL] [Abstract][Full Text] [Related]
5. TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells.
Zhao ZQ; Wu XJ; Cheng YH; Zhou YF; Ma XM; Zhang J; Heng XY; Feng F
CNS Neurosci Ther; 2021 Jun; 27(9):1064-76. PubMed ID: 34077623
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2.
Wang X; Liu C; Wang J; Tian Z
J Chemother; 2023 Nov; ():1-11. PubMed ID: 37968995
[TBL] [Abstract][Full Text] [Related]
7. Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway.
Fang F; Jin X; Meng J; He J; Wang J; Wang C; Xie S; Shi W
Cell Div; 2023 Dec; 18(1):22. PubMed ID: 38104091
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin.
Tung CH; Wu JE; Huang MF; Wang WL; Wu YY; Tsai YT; Hsu XR; Lin SH; Chen YL; Hong TM
Cancer Cell Int; 2023 Sep; 23(1):207. PubMed ID: 37726816
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated expression of TIPE3 inhibits malignant progression of non-small cell lung cancer via Wnt signaling.
Zong Z; Tang G; Guo Y; Kong F
Exp Cell Res; 2024 May; 439(2):114093. PubMed ID: 38759744
[TBL] [Abstract][Full Text] [Related]
10. ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway.
Shang B; Lu F; Jiang S; Xing M; Mao X; Yang G; Zhang H
Aging (Albany NY); 2023 Sep; 15(18):9614-9632. PubMed ID: 37724906
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of MCL-1 by LUCAT1 through interacting with SRSF1 promotes the migration and invasion in non-small cell lung carcinoma.
Fang F; Zhao M; Jin X; Dong Z; Wang J; Meng J; Xie S; Shi W
Mol Cell Biochem; 2023 Sep; ():. PubMed ID: 37747676
[TBL] [Abstract][Full Text] [Related]
12. TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin.
Zhao X; Jiang C; Xu R; Liu Q; Liu G; Zhang Y
Cancer Cell Int; 2020; 20():51. PubMed ID: 32082081
[TBL] [Abstract][Full Text] [Related]
13. BIRC3-HSP90B1 Interaction Inhibits Non-Small Cell Lung Cancer Progression through the Extracellular Signal-Regulated Kinase Pathway.
Suo F; Wu Y; Zhou Q; Li L; Wei X
ACS Omega; 2024 Apr; 9(17):19148-19157. PubMed ID: 38708247
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of PLA2R1 and RASSF9 in thyroid cancer and their inhibitory roles on the Wnt/β-catenin pathway and thyroid cancer cell malignant behaviors.
Xu Q; Yang H; Fan G; Zhang B; Yu J; Zhang Z; Jia G
Pathol Res Pract; 2022 Oct; 238():154092. PubMed ID: 36049438
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (
Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y
Front Oncol; 2023; 13():1334056. PubMed ID: 38053660
[TBL] [Abstract][Full Text] [Related]
16. TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression.
Zeng C; Zhang Y; Lin C; Liang W; Chen J; Chen Y; Xiao H; Li Y; Guan H
J Endocrinol Invest; 2024 May; ():. PubMed ID: 38753296
[TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract][Full Text] [Related]
18. Detection of DNA Methylation in Gene Loci ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 for Diagnosis of Cervical Cancer.
Fan C; Ma Q; Wu X; Dai X; Peng Q; Cai H
Cancer Manag Res; 2023; 15():635-644. PubMed ID: 37457377
[TBL] [Abstract][Full Text] [Related]
19. Increased methylation of ZNF671 suppresses tumor progression by promoting MAPK6 transcription in laryngeal carcinoma.
Zhang W; Liu T; Li X; Li T; Ma X; Zhao D; Zhao X
Int J Biol Sci; 2023; 19(8):2443-2457. PubMed ID: 37215982
[No Abstract] [Full Text] [Related]
20. The role of DNA methylation in ovarian cancer chemoresistance: A narrative review.
Song K; Artibani M
Health Sci Rep; 2023 May; 6(5):e1235. PubMed ID: 37123549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
